Global Biomarker Test Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: GAF3294D020CEN
QYResearch

Abstracts

This report focuses on the global Biomarker Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biomarker Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• F. Hoffmann-La Roche
• Novartis
• PFIZER
• GlaxoSmithKline
• GE Healthcare
• Medtronics
• Quest Diagnostics
• ...

Market segment by Type, the product can be split into

• Cancer
• Cardiovascular
• Infectious Diseases
• Central Nervous System

Market segment by Application, split into

• Pharma & Biotech Companies
• Diagnostic tool companies
• Healthcare IT/Big data companies
• Clinical laboratories

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Biomarker Test status, future forecast, growth opportunity, key market and key players.
• To present the Biomarker Test development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biomarker Test are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biomarker Test Revenue
1.4 Market Analysis by Type
  1.4.1 Global Biomarker Test Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Cancer
  1.4.3 Cardiovascular
  1.4.4 Infectious Diseases
  1.4.5 Central Nervous System
1.5 Market by Application
  1.5.1 Global Biomarker Test Market Share by Application: 2020 VS 2026
  1.5.2 Pharma & Biotech Companies
  1.5.3 Diagnostic tool companies
  1.5.4 Healthcare IT/Big data companies
  1.5.5 Clinical laboratories
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Biomarker Test Market Perspective (2015-2026)
2.2 Biomarker Test Growth Trends by Regions
  2.2.1 Biomarker Test Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Biomarker Test Historic Market Share by Regions (2015-2020)
  2.2.3 Biomarker Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Biomarker Test Market Growth Strategy
  2.3.6 Primary Interviews with Key Biomarker Test Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Biomarker Test Players by Market Size
  3.1.1 Global Top Biomarker Test Players by Revenue (2015-2020)
  3.1.2 Global Biomarker Test Revenue Market Share by Players (2015-2020)
  3.1.3 Global Biomarker Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biomarker Test Market Concentration Ratio
  3.2.1 Global Biomarker Test Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Biomarker Test Revenue in 2019
3.3 Biomarker Test Key Players Head office and Area Served
3.4 Key Players Biomarker Test Product Solution and Service
3.5 Date of Enter into Biomarker Test Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Biomarker Test Historic Market Size by Type (2015-2020)
4.2 Global Biomarker Test Forecasted Market Size by Type (2021-2026)

5 BIOMARKER TEST BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Biomarker Test Market Size by Application (2015-2020)
5.2 Global Biomarker Test Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Biomarker Test Market Size (2015-2020)
6.2 Biomarker Test Key Players in North America (2019-2020)
6.3 North America Biomarker Test Market Size by Type (2015-2020)
6.4 North America Biomarker Test Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Biomarker Test Market Size (2015-2020)
7.2 Biomarker Test Key Players in Europe (2019-2020)
7.3 Europe Biomarker Test Market Size by Type (2015-2020)
7.4 Europe Biomarker Test Market Size by Application (2015-2020)

8 CHINA

8.1 China Biomarker Test Market Size (2015-2020)
8.2 Biomarker Test Key Players in China (2019-2020)
8.3 China Biomarker Test Market Size by Type (2015-2020)
8.4 China Biomarker Test Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Biomarker Test Market Size (2015-2020)
9.2 Biomarker Test Key Players in Japan (2019-2020)
9.3 Japan Biomarker Test Market Size by Type (2015-2020)
9.4 Japan Biomarker Test Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Biomarker Test Market Size (2015-2020)
10.2 Biomarker Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Biomarker Test Market Size by Type (2015-2020)
10.4 Southeast Asia Biomarker Test Market Size by Application (2015-2020)

11 INDIA

11.1 India Biomarker Test Market Size (2015-2020)
11.2 Biomarker Test Key Players in India (2019-2020)
11.3 India Biomarker Test Market Size by Type (2015-2020)
11.4 India Biomarker Test Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Biomarker Test Market Size (2015-2020)
12.2 Biomarker Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Biomarker Test Market Size by Type (2015-2020)
12.4 Central & South America Biomarker Test Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 F. Hoffmann-La Roche
  13.1.1 F. Hoffmann-La Roche Company Details
  13.1.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
  13.1.3 F. Hoffmann-La Roche Biomarker Test Introduction
  13.1.4 F. Hoffmann-La Roche Revenue in Biomarker Test Business (2015-2020))
  13.1.5 F. Hoffmann-La Roche Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Biomarker Test Introduction
  13.2.4 Novartis Revenue in Biomarker Test Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 PFIZER
  13.3.1 PFIZER Company Details
  13.3.2 PFIZER Business Overview and Its Total Revenue
  13.3.3 PFIZER Biomarker Test Introduction
  13.3.4 PFIZER Revenue in Biomarker Test Business (2015-2020)
  13.3.5 PFIZER Recent Development
13.4 GlaxoSmithKline
  13.4.1 GlaxoSmithKline Company Details
  13.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.4.3 GlaxoSmithKline Biomarker Test Introduction
  13.4.4 GlaxoSmithKline Revenue in Biomarker Test Business (2015-2020)
  13.4.5 GlaxoSmithKline Recent Development
13.5 GE Healthcare
  13.5.1 GE Healthcare Company Details
  13.5.2 GE Healthcare Business Overview and Its Total Revenue
  13.5.3 GE Healthcare Biomarker Test Introduction
  13.5.4 GE Healthcare Revenue in Biomarker Test Business (2015-2020)
  13.5.5 GE Healthcare Recent Development
13.6 Medtronics
  13.6.1 Medtronics Company Details
  13.6.2 Medtronics Business Overview and Its Total Revenue
  13.6.3 Medtronics Biomarker Test Introduction
  13.6.4 Medtronics Revenue in Biomarker Test Business (2015-2020)
  13.6.5 Medtronics Recent Development
13.7 Quest Diagnostics
  13.7.1 Quest Diagnostics Company Details
  13.7.2 Quest Diagnostics Business Overview and Its Total Revenue
  13.7.3 Quest Diagnostics Biomarker Test Introduction
  13.7.4 Quest Diagnostics Revenue in Biomarker Test Business (2015-2020)
  13.7.5 Quest Diagnostics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Biomarker Test Key Market Segments
Table 2. Key Players Covered: Ranking by Biomarker Test Revenue
Table 3. Ranking of Global Top Biomarker Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biomarker Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cancer
Table 6. Key Players of Cardiovascular
Table 7. Key Players of Infectious Diseases
Table 8. Key Players of Central Nervous System
Table 9. Global Biomarker Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Biomarker Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Biomarker Test Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Biomarker Test Market Share by Regions (2015-2020)
Table 13. Global Biomarker Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Biomarker Test Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Biomarker Test Market Growth Strategy
Table 19. Main Points Interviewed from Key Biomarker Test Players
Table 20. Global Biomarker Test Revenue by Players (2015-2020) (Million US$)
Table 21. Global Biomarker Test Market Share by Players (2015-2020)
Table 22. Global Top Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Test as of 2019)
Table 23. Global Biomarker Test by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biomarker Test Product Solution and Service
Table 26. Date of Enter into Biomarker Test Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 29. Global Biomarker Test Market Size Share by Type (2015-2020)
Table 30. Global Biomarker Test Revenue Market Share by Type (2021-2026)
Table 31. Global Biomarker Test Market Size Share by Application (2015-2020)
Table 32. Global Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 33. Global Biomarker Test Market Size Share by Application (2021-2026)
Table 34. North America Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Biomarker Test Market Share (2019-2020)
Table 36. North America Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 37. North America Biomarker Test Market Share by Type (2015-2020)
Table 38. North America Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 39. North America Biomarker Test Market Share by Application (2015-2020)
Table 40. Europe Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Biomarker Test Market Share (2019-2020)
Table 42. Europe Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Biomarker Test Market Share by Type (2015-2020)
Table 44. Europe Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Biomarker Test Market Share by Application (2015-2020)
Table 46. China Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 47. China Key Players Biomarker Test Market Share (2019-2020)
Table 48. China Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 49. China Biomarker Test Market Share by Type (2015-2020)
Table 50. China Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 51. China Biomarker Test Market Share by Application (2015-2020)
Table 52. Japan Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Biomarker Test Market Share (2019-2020)
Table 54. Japan Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Biomarker Test Market Share by Type (2015-2020)
Table 56. Japan Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Biomarker Test Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Biomarker Test Market Share (2019-2020)
Table 60. Southeast Asia Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Biomarker Test Market Share by Type (2015-2020)
Table 62. Southeast Asia Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Biomarker Test Market Share by Application (2015-2020)
Table 64. India Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 65. India Key Players Biomarker Test Market Share (2019-2020)
Table 66. India Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 67. India Biomarker Test Market Share by Type (2015-2020)
Table 68. India Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 69. India Biomarker Test Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Biomarker Test Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Biomarker Test Market Share (2019-2020)
Table 72. Central & South America Biomarker Test Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Biomarker Test Market Share by Type (2015-2020)
Table 74. Central & South America Biomarker Test Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Biomarker Test Market Share by Application (2015-2020)
Table 76. F. Hoffmann-La Roche Company Details
Table 77. F. Hoffmann-La Roche Business Overview
Table 78. F. Hoffmann-La Roche Product
Table 79. F. Hoffmann-La Roche Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. PFIZER Company Details
Table 87. PFIZER Business Overview
Table 88. PFIZER Product
Table 89. PFIZER Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 90. PFIZER Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Product
Table 94. GlaxoSmithKline Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 95. GlaxoSmithKline Recent Development
Table 96. GE Healthcare Company Details
Table 97. GE Healthcare Business Overview
Table 98. GE Healthcare Product
Table 99. GE Healthcare Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 100. GE Healthcare Recent Development
Table 101. Medtronics Company Details
Table 102. Medtronics Business Overview
Table 103. Medtronics Product
Table 104. Medtronics Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 105. Medtronics Recent Development
Table 106. Quest Diagnostics Company Details
Table 107. Quest Diagnostics Business Overview
Table 108. Quest Diagnostics Product
Table 109. Quest Diagnostics Revenue in Biomarker Test Business (2015-2020) (Million US$)
Table 110. Quest Diagnostics Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Biomarker Test Market Share by Type: 2020 VS 2026
Figure 2. Cancer Features
Figure 3. Cardiovascular Features
Figure 4. Infectious Diseases Features
Figure 5. Central Nervous System Features
Figure 6. Global Biomarker Test Market Share by Application: 2020 VS 2026
Figure 7. Pharma & Biotech Companies Case Studies
Figure 8. Diagnostic tool companies Case Studies
Figure 9. Healthcare IT/Big data companies Case Studies
Figure 10. Clinical laboratories Case Studies
Figure 11. Biomarker Test Report Years Considered
Figure 12. Global Biomarker Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Biomarker Test Market Share by Regions: 2020 VS 2026
Figure 14. Global Biomarker Test Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Biomarker Test Market Share by Players in 2019
Figure 17. Global Top Biomarker Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Test as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Biomarker Test Revenue in 2019
Figure 19. North America Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Biomarker Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. F. Hoffmann-La Roche Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 30. PFIZER Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. PFIZER Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 34. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GE Healthcare Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 36. Medtronics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Medtronics Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 38. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Quest Diagnostics Revenue Growth Rate in Biomarker Test Business (2015-2020)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed